Very Low Calorie Diet Weight Loss
3 de fevereiro de 2022 atualizado por: Marielle PKJ Engelen, PhD, Texas A&M University
Omics Profiling of the Response to Food and Variability of Weight Loss in Medically Supervised Very Low Calorie Diet
Understanding how foods and nutrients are digested, absorbed and metabolized when weight is stable and during weight loss induced by very low calorie diet procedure using the technologies of genomics, transcriptomics, proteomics, metabolomics and fluxomics ("omics") will enable generation of new hypotheses that could explain the inter-individual differences in weight loss and could lead to optimization and individualization of therapies designed to lose weight.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
The overarching hypothesis is that there are baseline, pre- and post-diet combinations of 'omics' signatures in response to food and nutrients that explain the weight loss response of obese subjects to the very low calorie (VLC) diet.
In order to address the general hypothesis the following specific aims will be addressed:
Specific Aim 1: To test the hypothesis that there is a combination of 'omics' parameters in response to a defined meal that discriminate between morbidly obese subjects.
Specific Aim 2: To test the hypothesis that variation in % weight loss to the 2-weeks of VLC diet is related to baseline genomic markers, gene expression profile, proteomic and metabolomic signatures as well as baseline metabolic and substrates fluxomics response to a defined meal.
Specific Aim 3: To test the hypothesis that variation in % weight loss to the 4-weeks of VLC diet is related to baseline genomic markers, gene expression profile, proteomic and metabolomic signatures as well as baseline metabolic and substrates fluxomics response to a defined meal.
Tipo de estudo
Intervencional
Inscrição (Real)
56
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Texas
-
College Station, Texas, Estados Unidos, 77843
- Texas A&M University-CTRAL
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
30 anos e mais velhos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion criteria obese subjects:
Diagnosed with morbid obesity (defined as BMI > 40 kg/m2 or BMI > 35 kg/m2 with at least one serious comorbidity (2013 NIH compendium guidelines)) Scheduled for medically supervised Very Low Calorie Diet Age 30 years and older Ability to lay in supine or elevated position for 5 hours Willingness and ability to comply with the protocol Exclusion Criteria Any condition that may interfere with the definition 'healthy subject' according to the investigator's judgment (for healthy control group only) Participation in Weight Loss Management Program within the last 6 months prior the first study day Presence of fever within the last 3 days Untreated metabolic diseases including hepatic or renal disorder unrelated to the primary disease Presence of acute illness or metabolically unstable chronic illness unrelated to the primary disease
· (Possible) pregnancy Any other condition according to the PI or nurse that would interfere with the study or safety of the patient Failure to give informed consent Use of protein or amino acid containing nutritional supplements within 3 days of first test day
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: obese
screening visit: body weight and composition by DXA, height, and vital signs will be assessed. Subjects may sign a medical release form to obtain medical and psychological information about them that will help determine study eligibility or can be used for later coding. 3 study days (one baseline, one approx 2 weeks of diet, one post-diet): muscle mass and function tests, resting energy expenditure, stable isotope infusions with blood draws, and questionnaires regarding quality of life, mood and depression, diet. |
como glicerol, D2O, tirosina, fenilalanina, glicose, arginina e citrulina
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Mudança na síntese líquida de proteínas de todo o corpo
Prazo: 0, 2, 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 150, 180, 210, 225, 240, 260, 280, 300, 320, 340, 360 ± 5 min
|
Mudança na taxa de síntese de proteínas de todo o corpo após a ingestão da refeição
|
0, 2, 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 150, 180, 210, 225, 240, 260, 280, 300, 320, 340, 360 ± 5 min
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Group differences in state of mood as measured by the Hospital Anxiety and Depression Scale (HADS)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
a fourteen item self-assessment scale.
Seven of the items related to anxiety and seven relate to depression.
Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Executive Function-Adolescent/Adult Sensory Profile (ASP)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
a standardized self-questionnaire that generates an individualized profile of sensory processing across four quadrants: low registration, sensation seeking, sensory sensitivity, and sensation avoiding.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in quality of life as measured by Short Form (36) Health Survey (SF36)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
self administered questionnaire that measures each of the following eight health concepts: Physical Functioning (PF); Role-Physical (RP); Bodily Pain (BP); General Health (GH); Vitality (VT); Social Functioning (SF); Role-Emotional (RE); Mental Health (MH) as well as a reported Health Transition item (HT)
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in activity as measured by Physical Activity Scale for the Elderly (PASE)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
questionnaire is intended for use in an elderly population and focuses on 3 types of activities: leisure time activities, household activities and work-related activities.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in attention and executive functions as measured by Stroop Color-Word Test (SCWT)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
a word page with words printed in black ink, a color page with blocks printed in color, and a color-word page where the color and the word do not match.
The examinee reads the words or names the ink colors as quickly as possible within a time limit.
Measures selective attention and inhibitory control.
The total time in seconds was reported for each trial.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in state of mood as measured by the Profile of Mood State (POMS)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
A psychological distress scale to measure mood disturbance in 6 domains - fatigue-inertia, vigor-activity, tension-anxiety, depression-dejection, anger-hostility, and confusion-bewilderment.
Healthy populations take 3 to 7 minutes to complete, and others may take up a bit longer.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in learning and memory as measured by Controlled Oral Word Association Test (COWAT)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
Controlled Oral Word Association Test (COWAT): The examinee is required to say as many words as they can think of in one minute that begin with a given letter of the alphabet.
The task contains three trials.
Measures phonetic verbal fluency.
The raw score (total and mean words recorded across the three trials) was reported.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in learning and memory as measured by Auditory Verbal Learning Test (AVLT)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
Auditory Verbal Learning Test (AVLT): a verbal episodic memory test that evaluates a wide diversity of functions: short-term auditory-verbal memory, rate of learning, retention and recognition of information
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in attention and executive functions as measured by PASAT
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
a measure of cognitive function that assesses auditory information processing speed and flexibility, as well as calculation ability.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in attention and executive functions as measured by Trail Making Test (TMT)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
In Part A, the examinee is instructed to connect a set of 25 circles with numbers as quickly as possible while maintaining accuracy.
In Part B, the examinee is instructed to connect a set of 25 circles, alternating between numbers and letters, as quickly as possible while maintaining accuracy.
Measures attentional resources and is a measure of the frontal lobe "executive" functions of visual search, set-switching and mental flexibility.
The total time in seconds was reported for each measure.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in overall cognitive abilities as measured by Montreal Cognitive Assessment (MoCA)
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
assesses several cognitive domains and is used for the screening of mild cognitive impairment.
Total scores range from 0-30 with lower scores indicating decreased functioning.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Group differences in attention and executive functions as measured by Brief-A
Prazo: Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
a standardized self-report that captures views of an adult's executive functions or self-regulation in his or her everyday environment.
|
Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
|
|
Skeletal muscle strength
Prazo: on study day 1 and the change from day 2 and day 3
|
handgrip and kin-com 1-leg test
|
on study day 1 and the change from day 2 and day 3
|
|
24 hour diet recall
Prazo: on study day 1 and the change from day 2 and day 3
|
The subject is asked to recall in detail all the food and drink consumed during the 24 hours prior to the test day.
|
on study day 1 and the change from day 2 and day 3
|
|
Respiratory muscle strength
Prazo: on study day 1 and the change from day 2 and day 3
|
Maximum inhalation and exhalation pressure
|
on study day 1 and the change from day 2 and day 3
|
|
Body Composition
Prazo: on study day 1 and the change from day 2 and day 3
|
Body composition as measured by Dual-Energy X-ray Absorptiometry on study day 1 and the change from day 2 and day 3
|
on study day 1 and the change from day 2 and day 3
|
|
Gut function
Prazo: postabsorptive and prandial state every 20 minutes up to 6 hours before each sip feeding on day 1 and the change from day 2 and day 3
|
Digestion of the stable tracers of amino acid
|
postabsorptive and prandial state every 20 minutes up to 6 hours before each sip feeding on day 1 and the change from day 2 and day 3
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Marielle Engelen, Texas A&M University
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
1 de maio de 2016
Conclusão Primária (Real)
1 de outubro de 2018
Conclusão do estudo (Real)
1 de outubro de 2018
Datas de inscrição no estudo
Enviado pela primeira vez
19 de maio de 2016
Enviado pela primeira vez que atendeu aos critérios de CQ
19 de maio de 2016
Primeira postagem (Estimativa)
23 de maio de 2016
Atualizações de registro de estudo
Última Atualização Postada (Real)
4 de fevereiro de 2022
Última atualização enviada que atendeu aos critérios de controle de qualidade
3 de fevereiro de 2022
Última verificação
1 de fevereiro de 2022
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- IRB2016-0304
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .